US Venture Partners X LP's Form 4 filing
eFFECTOR Therapeutics, Inc. (EFTR) · filed Nov 12, 2021
- Accession no.
- 0001062993-21-010758
- Filed
- Nov 12, 2021, 5:52 PM ET
- Trade date
- Nov 9-12, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 0 derivative transactions. Open-market sales total $917.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| US Venture Partners X LPCIK 0001440514 | 10% Owner |
| Usvp X Affiliates LPCIK 0001453359 | 10% Owner |
| Tansey Casey MCIK 0001474322 | 10% Owner |
| Presidio Management Group X LLCCIK 0001602744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2021 | Common Stock | SSaleDisposed | −27,892 | $11.00 | −$306,923.57 | 4,644,736 | Indirect | |
| Nov 9, 2021 | Common Stock | SSaleDisposed | −893 | $11.00 | −$9,826.57 | 148,593 | Indirect | |
| Nov 10, 2021 | Common Stock | SSaleDisposed | −32,946 | $10.44 | −$343,824.46 | 4,611,790 | Indirect | |
| Nov 10, 2021 | Common Stock | SSaleDisposed | −1,054 | $10.44 | −$10,999.54 | 147,539 | Indirect | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −11,644 | $10.37 | −$120,724.99 | 4,600,146 | Indirect | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −373 | $10.37 | −$3,867.26 | 147,166 | Indirect | |
| Nov 12, 2021 | Common Stock | SSaleDisposed | −11,628 | $10.07 | −$117,093.96 | 4,588,518 | Indirect | |
| Nov 12, 2021 | Common Stock | SSaleDisposed | −372 | $10.07 | −$3,746.04 | 146,794 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.